High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals

被引:20
作者
Consigny, PH
Cauquelin, B
Agnamey, P
Comby, E
Brasseur, P
Ballet, JJ [1 ]
Roussilhon, C
机构
[1] CHU Clemenceau, Lab Immunol & Immunopathol, UPRES EA 2128, F-14033 Caen, France
[2] Fac Med Pharm, Parasitol Lab, UPRES 3234, Rouen, France
[3] Inst Pasteur, Unite Parasitol Biomed, Paris, France
关键词
anticardiolipin antibodies; malaria; serum co-factor;
D O I
10.1046/j.1365-2249.2002.01722.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Anticardiolipin antibodies (aCL) were investigated in 137 individuals chronically exposed to malaria and living in Africa and Asia. They belonged to several groups according to parasite (Plasmodium falciparum or vivax ) and clinical manifestations (i.e. asymptomatic parasite carriers, acute uncomplicated attack or severe malaria episodes). aCL were measured in an enzyme immunoassay (ELISA) performed in the presence of either goat serum (aCLs) or gelatin (aCLg). In a group of 53 patients with autoimmune manifestations (i.e. antiphospholipid syndrome and/or lupus), detection of IgG but not IgM aCL was markedly reduced in the presence of gelatin. In malaria donors, high prevalence of serum co-factor-independent IgG and IgM were detected, and the presence of goat serum in the assay consistently decreased their detection. aCLg levels were found to be related to the clinical/endemic status of donors. IgG aCLg were found to be higher in asymptomatic P. falciparum carriers than in patients with uncomplicated acute or cerebral malaria. IgM aCLg were higher in the cerebral malaria group than in groups with uncomplicated acute malaria patients or asymptomatic individuals. Data suggest that using a serum co-factor independent, sensitive ELISA, aCL are commonly detected during malarial infections and related to malarial infection status.
引用
收藏
页码:158 / 164
页数:7
相关论文
共 48 条
[1]
ADEBAJO AO, 1993, CLIN EXP IMMUNOL, V92, P73, DOI 10.1111/j.1365-2249.1993.tb05950.x
[2]
MEASUREMENT OF ANTIPHOSPHOLIPID ANTIBODIES BY ELISA USING BETA-2-GLYCOPROTEIN-I AS AN ANTIGEN [J].
ARVIEUX, J ;
ROUSSEL, B ;
JACOB, MC ;
COLOMB, MG .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 143 (02) :223-229
[3]
BATE CAW, 1992, IMMUNOLOGY, V76, P35
[4]
Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: Pathophysiological implications [J].
Bevers, EM ;
Comfurius, P ;
Zwaal, RFA .
LUPUS, 1996, 5 (05) :480-487
[5]
Bordmann G, 1998, IMMUNOLOGY, V94, P35, DOI 10.1046/j.1365-2567.1998.00479.x
[6]
COLACO CB, 1985, CLIN EXP IMMUNOL, V59, P449
[7]
REGULATION OF PHOSPHOLIPID ASYMMETRY AND INDUCTION OF ANTIPHOSPHOLIPID ANTIBODIES [J].
COMFURIUS, P ;
BEVERS, EM ;
GALLI, M ;
ZWAAL, RFA .
LUPUS, 1995, 4 :S19-S22
[8]
Autoimmunity and malaria: what are they doing together? [J].
Daniel-Ribeiro, CT ;
Zanini, G .
ACTA TROPICA, 2000, 76 (03) :205-221
[9]
Das BK, 1996, CLIN EXP IMMUNOL, V103, P442
[10]
Day HM, 1998, J RHEUMATOL, V25, P667